Asset Details
Do you wish to reserve the book?
Epigenetic Mechanisms of Human Papillomavirus–Associated Head and Neck Cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Epigenetic Mechanisms of Human Papillomavirus–Associated Head and Neck Cancer
Do you wish to request the book?
Epigenetic Mechanisms of Human Papillomavirus–Associated Head and Neck Cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Epigenetic Mechanisms of Human Papillomavirus–Associated Head and Neck Cancer
2015
Overview
Growing evidence suggests that as many as half of all oropharyngeal squamous cell carcinomas (OPSCCs) harbor human papillomavirus (HPV) infections. Despite being more advanced at diagnosis, HPV-positive OPSCCs are associated with a better response to therapy and longer patient survival than HPV-negative OPSCCs. Human papillomavirus-positive OPSCC has also been shown to have distinct host gene expression profiles compared with HPV-negative OPSCC. Recently, this distinction has been shown to include the epigenome. It is well supported that cancers are epigenetically deregulated. This review highlights epigenetic differences between HPV-positive and HPV-negative OPSCCs. The epigenetic mechanisms highlighted include methylation changes to host and viral DNA, and host chromatin modification. We also review the current evidence regarding host DNA methylation changes associated with smoking, and deregulation of microRNA expression in HPV-positive OPSCC.
To provide an overview of epigenetic mechanisms reported in HPV-positive OPSCC, with analogies to cervical cancer, and discussion of the challenges involved in studying epigenetic changes in HPV-associated OPSCC in combination with changes associated with smoking.
Sources were a literature review of peer-reviewed articles in PubMed on HPV and either OPSCC or head and neck squamous cell carcinoma, and related epigenetic mechanisms.
Epigenetic changes are reported to be a contributing factor to maintaining a malignant phenotype in HPV-positive OPSCC. The epigenetic mechanisms highlighted in this review can be studied for potential as biomarkers or as drug targets. Furthermore, continued research on the deregulation of epigenetic mechanisms in HPV-positive OPSCC (compared with HPV-negative OPSCC) may contribute to our understanding of the clinical and biologic differences between HPV-positive and HPV-negative OPSCC.
Publisher
College of American Pathologists
Subject
Carcinoma, Squamous Cell - complications
/ Carcinoma, Squamous Cell - genetics
/ Carcinoma, Squamous Cell - therapy
/ Genes
/ Head and Neck Neoplasms - complications
/ Head and Neck Neoplasms - genetics
/ Head and Neck Neoplasms - therapy
/ Humans
/ Oropharyngeal Neoplasms - complications
/ Oropharyngeal Neoplasms - genetics
/ Oropharyngeal Neoplasms - therapy
/ Papillomavirus Infections - complications
/ Smoking
